Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.62 in the last session, up 1.13% from day before closing price of $0.61. In other words, the price has increased by $1.13 from its previous closing price. On the day, 0.79 million shares were traded. KPTI stock price reached its highest trading level at $0.6295 during the session, while it also had its lowest trading level at $0.5905.
Ratios:
We take a closer look at KPTI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Paulson Richard A. sold 4,099 shares for $0.65 per share. The transaction valued at 2,664 led to the insider holds 1,120,158 shares of the business.
Paulson Richard A. sold 4,055 shares of KPTI for $3,175 on Jan 06 ’25. The President and CEO now owns 1,124,257 shares after completing the transaction at $0.78 per share. On Dec 04 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,620 shares for $0.81 each. As a result, the insider received 2,932 and left with 1,128,312 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 77809368 and an Enterprise Value of 211501920. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52. Its current Enterprise Value per Revenue stands at 1.425 whereas that against EBITDA is -1.683.
Stock Price History:
The Beta on a monthly basis for KPTI is 0.09, which has changed by -0.49008262 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, KPTI has reached a high of $1.70, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -9.88%, while the 200-Day Moving Average is calculated to be -26.71%.
Shares Statistics:
According to the various share statistics, KPTI traded on average about 898.43K shares per day over the past 3-months and 848490 shares per day over the past 10 days. A total of 125.30M shares are outstanding, with a floating share count of 116.47M. Insiders hold about 7.71% of the company’s shares, while institutions hold 47.39% stake in the company. Shares short for KPTI as of 1738281600 were 20136096 with a Short Ratio of 22.41, compared to 1735603200 on 19461323. Therefore, it implies a Short% of Shares Outstanding of 20136096 and a Short% of Float of 16.08.
